Cimetidine hydrochloride(CAS: 70059-30-2)

Cimetidine hydrochloride (CAS: 70059-30-2) is subject to regulatory guidelines under the Globally Harmonized System (GHS) for classification and labeling of chemicals. In the European Union, it falls under REACH regulations, requiring manufacturers and importers to register substances above a certain tonnage threshold. The U.S. FDA and EPA have specific requirements for the use and regulation of this compound in pharmaceuticals and environmental protection, respectively.

Alternative compounds to cimetidine hydrochloride (CAS: 70059-30-2) in synthesis include other histamine H2 receptor antagonists such as ranitidine and famotidine. These can be used as substitutes depending on the specific application and synthesis route. Isomers and analogs may also be explored, but thorough testing is necessary to ensure efficacy and safety.

The market for cimetidine hydrochloride (CAS: 70059-30-2) is primarily driven by its use as a proton pump inhibitor in treating gastrointestinal disorders. Research trends are shifting towards understanding its long-term effects and exploring potential alternative uses, such as in cancer therapy. Market analysis indicates a stable demand with a focus on safety and efficacy, particularly in light of recent regulatory challenges.

Waste containing cimetidine hydrochloride (CAS: 70059-30-2) should be collected in appropriate containers and disposed of according to local and national regulations. Incineration is a common method for disposal, but professional waste disposal services are recommended for larger quantities. Environmental protection measures include ensuring no contamination of soil or water sources, and following all safety precautions during handling and disposal.